Study: NCT03170960

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at the Cohort Review Committee-determined recommended dose from the Dose Escalation Stage

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at 60 mg qd

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at 60 mg qd

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cabozantinib
Description: Supplied as 60-mg and 20-mg tablets; administered orally daily at 60 mg qd